Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4455562
Max Phase: Preclinical
Molecular Formula: C40H52N10O6
Molecular Weight: 768.92
Molecule Type: Unknown
Associated Items:
ID: ALA4455562
Max Phase: Preclinical
Molecular Formula: C40H52N10O6
Molecular Weight: 768.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CCN1CC#CCN(NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H](C(N)=O)CCCC1
Standard InChI: InChI=1S/C40H52N10O6/c1-4-19-49-20-11-10-18-32(35(42)51)45-38(54)33(23-28-14-6-5-7-15-28)47-39(55)34(24-29-25-43-31-17-9-8-16-30(29)31)46-37(53)27(3)44-40(56)50(22-13-12-21-49)48-36(52)26(2)41/h4-9,14-17,25-27,32-34,43H,1,10-11,18-24,41H2,2-3H3,(H2,42,51)(H,44,56)(H,45,54)(H,46,53)(H,47,55)(H,48,52)/t26-,27-,32-,33+,34-/m0/s1
Standard InChI Key: ZIBQBUFAUUCDRK-UYBBICMOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 768.92 | Molecular Weight (Monoisotopic): 768.4071 | AlogP: 0.35 | #Rotatable Bonds: 9 |
Polar Surface Area: 236.88 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.39 | CX Basic pKa: 8.11 | CX LogP: 0.90 | CX LogD: -0.55 |
Aromatic Rings: 3 | Heavy Atoms: 56 | QED Weighted: 0.11 | Np Likeness Score: 0.28 |
1. Danelius E, Ohm RG, Ahsanullah, Mulumba M, Ong H, Chemtob S, Erdelyi M, Lubell WD.. (2019) Dynamic Chirality in the Mechanism of Action of Allosteric CD36 Modulators of Macrophage-Driven Inflammation., 62 (24): [PMID:31774287] [10.1021/acs.jmedchem.9b00918] |
2. (2018) Novel cyclic peptides and uses thereof, |
3. Ohm RG, Mulumba M, Chingle RM, Ahsanullah, Zhang J, Chemtob S, Ong H, Lubell WD.. (2021) Diversity-Oriented A3-Macrocyclization for Studying Influences of Ring-Size and Shape of Cyclic Peptides: CD36 Receptor Modulators., 64 (13.0): [PMID:34161728] [10.1021/acs.jmedchem.1c00642] |
Source(2):